149 related articles for article (PubMed ID: 2129379)
21. The state of lipid peroxidation and antioxidants following thrombolytic therapy with rt-PA and streptokinase in acute myocardial infarction.
Ozmen D; Boydak B; Mutaf I; Zoghi M; Kumanlioğlu K; Güner I; Bayindir O
Jpn Heart J; 1999 May; 40(3):267-73. PubMed ID: 10506849
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.
Owen J; Friedman KD; Grossman BA; Wilkins C; Berke AD; Powers ER
J Clin Invest; 1987 Jun; 79(6):1642-7. PubMed ID: 2953761
[TBL] [Abstract][Full Text] [Related]
23. Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis.
Hiatt MD
Cardiology; 1999; 91(4):243-9. PubMed ID: 10545680
[TBL] [Abstract][Full Text] [Related]
24. Laboratory assessment of thrombolytic therapy in acute myocardial infarction.
Talalak P; Chaithiraphan S; Opartkiattikul N; Leowattana W; Sangtawesin W; Tresukosol D
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():144-8. PubMed ID: 7886558
[TBL] [Abstract][Full Text] [Related]
25. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?
Collen D
Ann Intern Med; 1990 Apr; 112(7):529-38. PubMed ID: 2107781
[TBL] [Abstract][Full Text] [Related]
26. A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study).
Taylor GJ; Moses HW; Koester D; Colliver JA; Katholi RE; Dove JT; Woodruff RC; Mikell FL; Becker LC; Sheehan FH
Am J Cardiol; 1993 Nov; 72(14):1010-4. PubMed ID: 8213579
[TBL] [Abstract][Full Text] [Related]
27. Thrombolytic therapy in acute myocardial infarction.
Rutherford JD; Braunwald E
Chest; 1990 Apr; 97(4 Suppl):136S-145S. PubMed ID: 2108851
[TBL] [Abstract][Full Text] [Related]
28. Modern strategies for treatment of acute myocardial infarction: significance of haemostaseological and rheological findings.
Pindur G; Sen C; Wenzel E; Jung F; Ozbek C; Schwerdt H; Schieffer H; Bette L; Miyashita C
Adv Exp Med Biol; 1990; 281():389-94. PubMed ID: 2129376
[TBL] [Abstract][Full Text] [Related]
29. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
[TBL] [Abstract][Full Text] [Related]
30. Streptokinase and reduced plasma viscosity: a second benefit.
Moriarty AJ; Hughes R; Nelson SD; Balnave K
Eur J Haematol; 1988 Jul; 41(1):25-36. PubMed ID: 3402584
[TBL] [Abstract][Full Text] [Related]
31. [Tissue plasminogen activator (t-PA) in myocardial infarction. Biological aspects].
Samama M; Verdy E; Conard J; Vahanian A; Michel P; Van Dreden P; Nguyen G; Horellou MH; Combrisson A; Acar J
Arch Mal Coeur Vaiss; 1986 Oct; 79(11):1618-24. PubMed ID: 3103572
[TBL] [Abstract][Full Text] [Related]
32. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO.
Bates ER
Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479
[TBL] [Abstract][Full Text] [Related]
33. Can streptokinase produce beneficial effects additional to coronary recanalization? Quantitative microvascular analysis of critically injured reperfused myocardium.
Woo KS; Armiger LC; White HD; Norris RM
Microvasc Res; 2000 Jul; 60(1):8-20. PubMed ID: 10873510
[TBL] [Abstract][Full Text] [Related]
34. Creation of the recombinant tissue plasminogen activator (rt-PA) image and its influence on practice habits.
Sherry S; Marder VJ
J Am Coll Cardiol; 1991 Nov; 18(6):1579-82. PubMed ID: 1939964
[TBL] [Abstract][Full Text] [Related]
35. Blood viscosity during thrombolytic therapy with anistreplase in acute myocardial infarction.
Hoffmann JJ; Bonnier JJ; Melman PG; Bartholomeus I
Am J Cardiol; 1993 Jan; 71(1):14-8. PubMed ID: 8420229
[TBL] [Abstract][Full Text] [Related]
36. Platelet function after in vivo and in vitro treatment with thrombolytic agents.
Bertolino G; Noris P; Previtali M; Gamba G; Ferrario M; Montani N; Balduini CL
Am J Cardiol; 1992 Feb; 69(5):457-61. PubMed ID: 1736606
[TBL] [Abstract][Full Text] [Related]
37. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
GUSTO investigators
N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
[TBL] [Abstract][Full Text] [Related]
38. Alteration of the fibrinogen molecule and its phosphorylation state in myocardial infarction patients undergoing thrombolytic treatment.
Haglund AC; Ronquist G; Frithz G; Ek P
Thromb Res; 2000 Apr; 98(2):147-56. PubMed ID: 10713316
[TBL] [Abstract][Full Text] [Related]
39. Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia.
Barbash GI; Hod H; Roth A; Faibel HE; Mandel Y; Miller HI; Rath S; Zahav YH; Rabinowitz B; Seligsohn U
J Am Coll Cardiol; 1990 Oct; 16(4):779-83. PubMed ID: 2120309
[TBL] [Abstract][Full Text] [Related]
40. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
